03:27 AM EST, 11/17/2025 (MT Newswires) -- Simrat Randhawa, Executive Vice President, Head of Research & Development, on November 13, 2025, sold 196,538 shares in Dianthus Therapeutics ( DNTH ) for $7,379,887. Following the Form 4 filing with the SEC, Randhawa has control over a total of 4,000 common shares of the company, with 4,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1690585/000199226025000008/xslF345X05/ownership.xml